Pharmacy Groups File Suit To Stop New Medicaid Drug Payment System
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharmacies could lose $8 billion over next five years if data used to set average manufacturer prices includes mail-order, clinic and physician sales, trade groups assert.
You may also be interested in...
Drug Makers Must Continue AMP Medicaid Calculations, Despite Court Ruling
Dec. 19 federal court injunction bars CMS from publishing AMP data for now.
Drug Makers Must Continue AMP Medicaid Calculations, Despite Court Ruling
Dec. 19 federal court injunction bars CMS from publishing AMP data for now.
AMP-Based Drug Reimbursement Not Enticing Many States, Survey Shows
More state Medicaid directors say they will not consider AMPs to set rates for brand-name drugs in 2008.